Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-01-30 | D/A | $213.3M | 98 | |
| 2026-01-23 | D/A | $217.5M | 102 | +$4.2M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor. All Ikarian Healthcare vehicles →
Sold rose to $NaN (+$4.2M, +4 investors) in 358 days since the previous filing.
Sold rose to $NaN (+$2M, +3 investors) in 364 days since the previous filing.
| Neil Shahrestani | Executive Officer |
| Joe Hardiman | Director |
| Sophia Dilbert | Director |
| N/A Ikarian Capital, LLC | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Troy Wuertz, Chief Compliance Officer of the Investment Manager.
Relevant to: Fund audit & tax, Fund administrator.
The issuer's phone number and address from the filing are shown to subscribers. See plans.
